CLINICAL_TRIALS
research
· 2024-12-27
Clinical Trial Update: Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder [NA]
Summary
A Pharmaco(Epi)Genetic, Proteomic, and Microbiomic study focusing on obsessive-compulsive disorder is currently recruiting. Sponsored by Severance Hospital.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Severance Hospital | Conditions: Obsessive-Compulsive Disorder | NA | Status: RECRUITING